Press Release Archive

The information in these news pages is accurate or current only as of the date of the particular press release or posting. Gilead does not update press releases once they have been made public. Press releases may contain forward-looking statements. Actual results could vary dramatically as a result of known and unknown risks and uncertainties.

November 14, 2008
Gilead Sciences Announces Notification of ANDA Filing for Truvada

November 5, 2008
Gilead Sciences to Present at Three Upcoming Investor Conferences

November 1, 2008
Gilead Announces Two-Year Data from Pivotal Phase III Studies Evaluating Viread(R) for Chronic Hepatitis B

October 30, 2008
Gilead Sciences to Present at the Oppenheimer 19th Annual Healthcare Conference on Tuesday, November 4

October 28, 2008
Gilead Announces Two-Year Clinical Data for Letairis(R) (ambrisentan) for the Treatment of Pulmonary Arterial Hypertension (WHO Group 1)